Induction of protective immunity against pathogenic simian immunodeficiency virus by a foreign receptor-dependent replication of an engineered avirulent virus

Vaccine

Volumn 18, Issue 28, 2000, Pages 3310-3318

  Matano, Tetsuro ^a   Kano, Munehide ^a   Odawara, Takashi ^a   Nakamura, Hiromi ^a   Takeda, Akiko ^a   Mori, Kazuyasu ^a   Sato, Tetsutaro ^a   Nagai, Yoshiyuki ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

AIDS vaccine; Cellular immune response; SIV

Indexed keywords

DNA VACCINE; LIVE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CHIMERA; CONTROLLED STUDY; IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0034257004     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00122-5     Document Type: Article

References (33)

1. Johnson R.P. Macaque models for AIDS vaccine development. Curr. Opin. Immunol. 8:1996;554-560.
2. Almond N.M., Heeney J.L. AIDS vaccine development in primate models. AIDS. 12:1998;133-140.
3. Daniel M.D., Kirchhoff F., Czajak S.C., Sehgal P.K., Desrosiers R.C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science. 258:1992;1938-1941.
4. Shibata R., Siemon C., Czajak S.C., Desrosiers R.C., Martin M.A. Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus. J. Virol. 71:1997;8141-8148.
5. Baba T.W., Jeong Y.S., Pennick D., Bronson R., Greene M.F., Ruprecht R.M. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science. 267:1995;1820-1825.
6. Baba T.W., Liska V., Khimani A.H., et al. Live, attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat. Med. 5:1999;194-203.
7. Burton D.R., Moore J.P. Why do we not have an HIV vaccine and how can we make one? Nat. Med. 4:1998;495-498.
8. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA vaccines. Annu. Rev. Immunol. 15:1997;617-648.
9. Lu S., Arthos J., Montefiori D.C., et al. Simian immunodeficiency virus DMA vaccine trial in macaques. J. Virol. 70:1996;3978-3991.
10. Albritton L.M., Tweng L., Scadden D., Cunningham J.M. A putative murine retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell. 57:1989;659-666.
11. Coffin J.M., Hughes S.H., Varmus H.E. Retroviruses. 1997;CSHL Press, New York.
12. Shibata R., Maldarelli F., Siemon C., et al. Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: determinants of high virus loads and CD4 cell killing. J. Infect. Dis. 176:1997;362-373.
13. Shibata R., Hoggan M.D., Broscius C., et al. Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo. J. Virol. 69:1995;4453-4462.
14. Matano T., Odawara T., Ohshima M., Yoshikura H., Iwamoto A. Trans-dominant interference with virus infection at two different stages by a mutant envelope protein of Friend murine leukemia virus. J. Virol. 67:1993;2026-2033.
15. Koch W., Hunsmann G., Friedrich R. Nucleotide sequence of the envelope gene of Friend murine leukemia virus. J. Virol. 45:1983;1-9.
16. Kestler H., Kodama T., Ringler D., et al. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science. 248:1990;1109-1112.
17. Hasan M.K., Kato A., Shioda T., Sakai Y., Yu D., Nagai Y. Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3′ proximal first locus. J. Gen. Virol. 78:1997;2813-2820.
18. Mackett M., Smith G.L., Moss B. Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc. Natl. Acad. Sci. USA. 79:1982;7415-7419.
19. Voss G., Nick S., Stahl-Hennig C., Ritter K., Hunsmann G. Generation of macaque B lymphoblastoid cell lines with simian Epstein-Barr-like viruses: transformation procedure, characterization of the cell lines and occurrence of simian foamy virus. J. Virol. Methods. 39:1992;185-195.
20. Voss G., Li J., Manson K., Wyand M., Sodroski J., Letvin N.L. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys. Virology. 208:1995;770-775.
21. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:1938;493-497.
22. Leonard W.J. Type I cytokines and interferons and their receptors. Paul W.E. Fundamental immunology. 1999;741-774 Lippincott-Raven, Philadelphia.
23. Dittmer U., Brooks D.M., Hasenkrug K.J. Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection. Nat. Med. 5:1995;189-193.
24. Zarozinski C.C., Fynan E.F., Selin L.K., Robinson H.L., Welsh R.M. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol. 154:1995;4010-4017.
25. Geretti A.M., Hulskotte E., Osterhaus A.D.M.E. Cytotoxic T lymphocytes in AIDS pathogenesis: lessons to be learned from the macaque model of simian immunodeficiency virus infection. J. Gen. Virol. 79:1998;415-421.
26. Ogg G.S., Jin X., Bonhoeffer S., et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 279:1998;2103-2106.
27. Matano T., Shibata R., Siemon C., Connors M., Lane H.C., Martin M.A. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72:1998;164-169.
28. Schmitz J.E., Kuroda M.J., Santra S., et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 283:1999;857-860.
29. Jin X., Bauer D.E., Tuttleton S.E., et al. Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189:1999;991-998.
30. Kundig T.M., Bachmann M.F., DiPaolo C., et al. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science. 268:1995;1343-1347.
31. Sigal L.J., Crotty S., Andino R., Rock K.L. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature. 398:1999;77-80.
32. Kim J.J., Bagarazzi M.L., Trivedi N., et al. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nat. Biotechnol. 15:1997;641-646.
33. Lewis M.G., Bellah S., McKinnon K., et al. Titration and characterization of two rhesus-derived SIVmac challenge stocks. AIDS Res. Hum. Retroviruses. 10:1994;213-220.